C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

Background—In addition to being a risk marker for cardiovascular disease, much recent data suggest that C-reactive protein (CRP) promotes atherogenesis. Decreased endothelial NO and prostacyclin (PGI2) contribute to a proatherogenic and prothrombotic state. We have shown that CRP decreases endothelial NO synthase expression and bioactivity in human aortic endothelial cells (HAECs). PGI2 is a potent vasodilator and inhibitor of platelet aggregation. Hence, the aim of this study was to examine the effect of CRP on PGI2 release from HAECs and human coronary artery endothelial cells (HCAECs). Methods and Results—HAECs and HCAECs were incubated with human CRP (0 to 50 &mgr;g/mL for 24 hours). The release of PGF-1&agr;, a stable product of PGI2, was also assayed in the absence and presence of a potent agonist, A23187. CRP significantly decreased PGF-1&agr; release from HAECs under basal (48% decrease, P <0.001; n=5) and stimulated (26% decrease, P <0.01; n=5) conditions. CRP had no effect on PGI2 synthase (PGIS) mass. By increasing both superoxide and inducible NO synthase, CRP resulted in increased nitration of PGIS by peroxynitrite. The increased nitration and decreased activity of PGIS by CRP was reversed with peroxynitrite scavengers. Conclusions—Thus, CRP decreases PGI2 release from HAECs by inactivating PGIS via nitration, additionally contributing to its atherogenicity.

[1]  E. Edelman,et al.  Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice , 2003, Circulation.

[2]  N. Youhnovski,et al.  Specific Nitration at Tyrosine 430 Revealed by High Resolution Mass Spectrometry as Basis for Redox Regulation of Bovine Prostacyclin Synthase* , 2003, The Journal of Biological Chemistry.

[3]  Edward T H Yeh,et al.  Coming of age of C-reactive protein: using inflammation markers in cardiology. , 2003, Circulation.

[4]  S. Devaraj,et al.  C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis , 2003, Circulation.

[5]  Sridevi Devaraj,et al.  Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.

[6]  G. FitzGerald,et al.  Human prostacyclin receptor. , 2002, Vitamins and hormones.

[7]  S. Devaraj,et al.  Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. , 2001, American journal of clinical pathology.

[8]  F. Crea,et al.  Unstable Angina and Elevated C-Reactive Protein Levels Predict Enhanced Vasoreactivity of the Culprit Lesion , 2001, Circulation.

[9]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[10]  J. Connell,et al.  Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. , 2000, Clinical science.

[11]  M. Leist,et al.  Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. , 1999, The American journal of pathology.

[12]  V. Ullrich,et al.  Prostaglandin endoperoxide‐dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase , 1999, British journal of pharmacology.

[13]  M. Aoki,et al.  Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. , 1999, Stroke.

[14]  B. Halliwell,et al.  Assessment of peroxynitrite scavengers in vitro. , 1999, Methods in enzymology.

[15]  J. Beckman,et al.  Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. , 1998, Archives of biochemistry and biophysics.

[16]  S. Devaraj,et al.  The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. , 1996, The Journal of clinical investigation.

[17]  Harry,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.

[18]  J. Vane,et al.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. , 1978, Pharmacological reviews.